Comparing the safety and efficacy of remimazolam-based total intravenous anesthesia versus volatile agent-based anesthesia: a meta-analysis of randomized controlled trials

Background Remimazolam is a novel short-acting benzodiazepine that has recently been used for general anesthesia. This study compared the safety and efficacy of remimazolam-based total intravenous anesthesia (TIVA) and volatile agent-based anesthesia in adults undergoing general anesthesia. Methods...

Full description

Saved in:
Bibliographic Details
Main Authors: Ji-In Park, Hyo-Seok Na, Keum-O Lee, Jung-Hee Ryu, Hyun-Jung Shin
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2025-02-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kja-24444.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544935057817600
author Ji-In Park
Hyo-Seok Na
Keum-O Lee
Jung-Hee Ryu
Hyun-Jung Shin
author_facet Ji-In Park
Hyo-Seok Na
Keum-O Lee
Jung-Hee Ryu
Hyun-Jung Shin
author_sort Ji-In Park
collection DOAJ
description Background Remimazolam is a novel short-acting benzodiazepine that has recently been used for general anesthesia. This study compared the safety and efficacy of remimazolam-based total intravenous anesthesia (TIVA) and volatile agent-based anesthesia in adults undergoing general anesthesia. Methods We searched electronic databases including PubMed, Embase, CENTRAL, and Scopus for relevant studies. The primary outcome was the proportion of patients who experienced hypotension during surgery. Secondary outcomes included incidence of bradycardia, extubation time, duration in the post-anesthesia care unit hospital stay, and incidence of postoperative nausea and/or vomiting (PONV). We estimated the relative risk (RR) and mean difference with 95% CIs using a random-effects model. Results A total of 969 patients from 12 randomized controlled trials were included. The incidence of hypotension was 14% and 34% in the remimazolam and volatile agent groups, respectively. Remimazolam significantly lowered the incidence of hypotension (RR: 0.43, 95% CI [0.29–0.63], P = 0.0000, I2 = 26%). The remimazolam group had a PONV incidence of 13%, compared to 28% in the volatile agent group, indicating a significant difference (RR: 0.51, 95% CI [0.37–0.72], P = 0.0001, I2 = 15%). No significant differences were observed in the other outcomes. Conclusions Remimazolam-based TIVA demonstrated favorable hemodynamic effects, with a lower incidence of hypotension and similar bradycardia rates, compared to volatile agent-based anesthesia. Furthermore, the reduction in PONV supports the use of remimazolam-based TIVA as a valuable method for general anesthesia.
format Article
id doaj-art-0a2dce422e434dd1a9889d9a420463f2
institution Kabale University
issn 2005-6419
2005-7563
language English
publishDate 2025-02-01
publisher Korean Society of Anesthesiologists
record_format Article
series Korean Journal of Anesthesiology
spelling doaj-art-0a2dce422e434dd1a9889d9a420463f22025-02-03T08:32:46ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632025-02-01781486010.4097/kja.244449024Comparing the safety and efficacy of remimazolam-based total intravenous anesthesia versus volatile agent-based anesthesia: a meta-analysis of randomized controlled trialsJi-In Park0Hyo-Seok Na1Keum-O Lee2Jung-Hee Ryu3Hyun-Jung Shin4 Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, KoreaBackground Remimazolam is a novel short-acting benzodiazepine that has recently been used for general anesthesia. This study compared the safety and efficacy of remimazolam-based total intravenous anesthesia (TIVA) and volatile agent-based anesthesia in adults undergoing general anesthesia. Methods We searched electronic databases including PubMed, Embase, CENTRAL, and Scopus for relevant studies. The primary outcome was the proportion of patients who experienced hypotension during surgery. Secondary outcomes included incidence of bradycardia, extubation time, duration in the post-anesthesia care unit hospital stay, and incidence of postoperative nausea and/or vomiting (PONV). We estimated the relative risk (RR) and mean difference with 95% CIs using a random-effects model. Results A total of 969 patients from 12 randomized controlled trials were included. The incidence of hypotension was 14% and 34% in the remimazolam and volatile agent groups, respectively. Remimazolam significantly lowered the incidence of hypotension (RR: 0.43, 95% CI [0.29–0.63], P = 0.0000, I2 = 26%). The remimazolam group had a PONV incidence of 13%, compared to 28% in the volatile agent group, indicating a significant difference (RR: 0.51, 95% CI [0.37–0.72], P = 0.0001, I2 = 15%). No significant differences were observed in the other outcomes. Conclusions Remimazolam-based TIVA demonstrated favorable hemodynamic effects, with a lower incidence of hypotension and similar bradycardia rates, compared to volatile agent-based anesthesia. Furthermore, the reduction in PONV supports the use of remimazolam-based TIVA as a valuable method for general anesthesia.http://ekja.org/upload/pdf/kja-24444.pdfanesthesia, generalanesthesia, inhalationanesthesia, intravenouspostoperative nausea and vomitingremimazolamsafety
spellingShingle Ji-In Park
Hyo-Seok Na
Keum-O Lee
Jung-Hee Ryu
Hyun-Jung Shin
Comparing the safety and efficacy of remimazolam-based total intravenous anesthesia versus volatile agent-based anesthesia: a meta-analysis of randomized controlled trials
Korean Journal of Anesthesiology
anesthesia, general
anesthesia, inhalation
anesthesia, intravenous
postoperative nausea and vomiting
remimazolam
safety
title Comparing the safety and efficacy of remimazolam-based total intravenous anesthesia versus volatile agent-based anesthesia: a meta-analysis of randomized controlled trials
title_full Comparing the safety and efficacy of remimazolam-based total intravenous anesthesia versus volatile agent-based anesthesia: a meta-analysis of randomized controlled trials
title_fullStr Comparing the safety and efficacy of remimazolam-based total intravenous anesthesia versus volatile agent-based anesthesia: a meta-analysis of randomized controlled trials
title_full_unstemmed Comparing the safety and efficacy of remimazolam-based total intravenous anesthesia versus volatile agent-based anesthesia: a meta-analysis of randomized controlled trials
title_short Comparing the safety and efficacy of remimazolam-based total intravenous anesthesia versus volatile agent-based anesthesia: a meta-analysis of randomized controlled trials
title_sort comparing the safety and efficacy of remimazolam based total intravenous anesthesia versus volatile agent based anesthesia a meta analysis of randomized controlled trials
topic anesthesia, general
anesthesia, inhalation
anesthesia, intravenous
postoperative nausea and vomiting
remimazolam
safety
url http://ekja.org/upload/pdf/kja-24444.pdf
work_keys_str_mv AT jiinpark comparingthesafetyandefficacyofremimazolambasedtotalintravenousanesthesiaversusvolatileagentbasedanesthesiaametaanalysisofrandomizedcontrolledtrials
AT hyoseokna comparingthesafetyandefficacyofremimazolambasedtotalintravenousanesthesiaversusvolatileagentbasedanesthesiaametaanalysisofrandomizedcontrolledtrials
AT keumolee comparingthesafetyandefficacyofremimazolambasedtotalintravenousanesthesiaversusvolatileagentbasedanesthesiaametaanalysisofrandomizedcontrolledtrials
AT jungheeryu comparingthesafetyandefficacyofremimazolambasedtotalintravenousanesthesiaversusvolatileagentbasedanesthesiaametaanalysisofrandomizedcontrolledtrials
AT hyunjungshin comparingthesafetyandefficacyofremimazolambasedtotalintravenousanesthesiaversusvolatileagentbasedanesthesiaametaanalysisofrandomizedcontrolledtrials